Researchers have developed a way to 3D print custom micrometer-sized structures directly into the interior of living cells.
CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or the “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary technologies to develop novel ...
According to a Phase I study led by researchers at The University of Texas MD Anderson Cancer Center , published today in Nature Medicine , the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback